This is the text extract for February Tender Notification; Contact: Kyle Reid, browse documents here.

---

28 February 2011

TENDER RESULTS

The PHARMAC Board (or Chief Executive under Delegated Authority) has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2010/11 Invitation to Tender, dated 2 November 2010. As discussed in our 2010 tender consultation document, we intend to notify tender decisions as they are made in 2011. This change is to provide maximum notification of upcoming changes to the market, specifically to incumbent suppliers. We have, therefore, altered the layout of this notification letter. Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm 11th March 2011. More information and NOPC forms can be found on our website – www.pharmac.govt.nz/schedule.asp.

2010/11 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2014 Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

1. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

Current subsidy and price $100.00 New subsidy and price $50.00

The decisions were as follows:

Chemical name

Presentation; Pack size and type Oral liq 20 mg per ml; 240 ml OP, bottle

Sole supply brand (Supplier) Ziagen (GSK)

Date of subsidy change

Sole Subsidised Supply date

Abacavir sulphate

1 May 2011

1 August 2011

A383645 - qA18036

---

Chemical name

Presentation; Pack size and type Tab 300 mg; 60 tablets, blister Tab 25 mg; 100 tablets, blister Tab 50 mg; 100 tablets, blister Tab 2 mg; 500 tablets, bottle Tab 4 mg; 500 tablets, bottle Tab 25 mg; 30 tablets, blister Tab long-acting 40 mg; 30 tablets, blister Tab 20 mg; 100 tablets, blister Tab 10 mg; 100 tablets, bottle Tab 400 mg; 100 tablets, bottle

Current subsidy and price $458.00 $3.40 $5.20 $22.85 $30.26 $26.55 ($175.00) $14.84 $18.00 $5.15 $22.50

New subsidy and price $229.00 $1.85 $3.60 $8.23 $12.40 $22.57 $7.50 $17.10 $3.95 $15.45

Sole supply brand (Supplier) Ziagen (GSK) Amitrip (Mylan) Amitrip (Mylan) Apo-Doxazosin (Apotex) Apo-Doxazosin (Apotex) Aromasin (Pfizer) Corangin (Novartis) Ismo 20 (Riemser) Metamide (Mylan) Arrow-Norfloxacin (Arrow)

Date of subsidy change

Sole Subsidised Supply date

Abacavir sulphate Amitriptyline Amitriptyline Doxazosin mesylate Doxazosin mesylate Exemestane* Isosorbide mononitrate Isosorbide mononitrate Metoclopramide hydrochloride Norfloxacin

1 May 2011 1 April 2011 1 April 2011 1 April 2011 1 April 2011 1 April 2011 1 April 2011 1 April 2011 1 April 2011 1 April 2011

1 August 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011

* The current Special Authority for Alternate Subsidy applying to exemestane tab 25 mg in Section B of the Pharmaceutical Schedule will be removed from 1 April 2011

A383645 - qA18036

---

2.

Tenders awarded to pharmaceuticals where at least one other brand is listed.

Date of listing/subsidy change for tender winning brand 1 April 2011 1 April 2011 Sole Subsidised Brand (Supplier) Supply date (and affected by delisting of other reference pricing listed brands) and delisting 1 September 2011 1 September 2011 Apo-Ipravent (Apotex) Tamoxifen Sandoz (Sandoz)

The decisions were as follows:

Chemical Name

Presentation; Pack size and type Aqueous nasal spray, 0.03%; 15 ml bottle, 1 bottle Tab 20 mg; 100 tablets, blister

Current subsidy and price $12.66 (per 30 ml) $11.10

New subsidy and price $4.03 $8.75

Sole supply brand (Supplier) Univent (Rex Medical) Genox (Mylan)

Date of reference pricing of other listed brands 1 June 2011 1 June 2011

Ipratropium bromide Tamoxifen citrate

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 3. Tenders awarded to pharmaceuticals where no brand is listed.

Presentation; Pack size and type Oral liq 20 mg per ml; 240 ml, bottle Tab 300 mg; 60 tablets, blister Tab long-acting 40 mg; 30 tablets, blister Pack price $50.00 $229.00 $7.50 Hospital Supply Brand (Supplier) Ziagen (GSK) Ziagen (GSK) Corangin (Novartis) DV Limit 1% 1% 1% Listing date 1 May 2011 1 May 2011 1 April 2011 Hospital Supply Status date 1 July 2011 1 July 2011 1 June 2011

The decisions were as follows:

Chemical Name Abacavir sulphate Abacavir sulphate Isosorbide mononitrate

4.

Tenders awarded to listed pharmaceuticals where only the current brand is listed.

Presentation; Pack size and type Tab 25 mg; 100 tablets, blister Current pack price $3.40 New pack price $1.85 Hospital Supply Brand (Supplier) Amitrip (Mylan) DV Limit 1%

The decisions were as follows:

Chemical Name Amitriptyline

Date of price change 1 April 2011

Hospital Supply Status date 1 June 2011

A383645 - qA18036

---

Chemical Name Amitriptyline Doxazosin mesylate Doxazosin mesylate Exemestane Isosorbide mononitrate Metoclopramide hydrochloride Norfloxacin

Presentation; Pack size and type Tab 50 mg; 100 tablets, blister Tab 2 mg; 500 tablets, bottle Tab 4 mg 500 tablets, bottle Tab 25 mg; 30 tablets, blister Tab 20 mg; 100 tablets, blister Tab 10 mg; 100 tablets, bottle Tab 400 mg; 100 tablets, bottle

Current pack price $5.20 $22.85 $30.26 $175.00 $18.00 $5.15 $22.50

New pack price $3.60 $8.23 $12.40 $22.57 $17.10 $3.95 $15.45

Hospital Supply Brand (Supplier) Amitrip (Mylan) Apo-Doxazosin (Apotex) Apo-Doxazosin (Apotex) Aromasin (Pfizer) Ismo 20 (Riemser) Metamide (Mylan) Arrow-Norfloxacin (Arrow)

DV Limit 1% 1% 1% 1% 1% 1% 1%

Date of price change 1 April 2011 1 April 2011 1 April 2011 1 April 2011 1 April 2011 1 April 2011 1 April 2011

Hospital Supply Status date 1 June 2011 1 June 2011 1 June 2011 1 June 2011 1 June 2011 1 June 2011 1 June 2011

5.

Tenders awarded to listed pharmaceuticals where an alternative brand is already listed.

Presentation; Pack size and type Tab 20 mg; 100 tablets, blister Current pack price $11.10 New pack price $8.75 Hospital Supply Brand (Supplier) Genox (Mylan) DV Limit 1% Date of listing/price change for tender winning brand 1 April 2011 Hospital Supply Status date (and delisting of other listed brands) 1 June 2011 Brand (Supplier) to be delisted Tamoxifen Sandoz (Sandoz)

The decisions were as follows:

Chemical Name

Tamoxifen citrate

A383645 - qA18036

---

Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status The PHARMAC Board (or Chief Executive under Delegated Authority) resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2010/11 Invitation to Tender, dated 2 November 2010:

Chemical Name Benzbromarone Benzbromarone Benzbromarone Midazolam Line Item Tab 25 mg Tab 50 mg Tab 100 mg Tab 7.5 mg

For products included in the 2008/09 Invitation to Tender, 2009/10 Invitation to Tender and 2010/11 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or Chief Executive) approval. We will keep you informed of any updates regarding such tender products as decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A383645 - qA18036